| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/23/2022 | 40.44% | Credit Suisse | → $78 | Initiates Coverage On | → Outperform |
| 08/08/2022 | 44.04% | Baird | $75 → $80 | Maintains | Outperform |
| 07/21/2022 | 11.63% | RBC Capital | $45 → $62 | Maintains | Sector Perform |
| 07/18/2022 | 44.04% | Truist Securities | $85 → $80 | Maintains | Buy |
| 07/11/2022 | 15.23% | Morgan Stanley | → $64 | Downgrades | Overweight → Equal-Weight |
| 07/07/2022 | 45.84% | Canaccord Genuity | → $81 | Initiates Coverage On | → Buy |
| 05/13/2022 | 17.03% | Cowen & Co. | $80 → $65 | Maintains | Outperform |
| 05/13/2022 | 35.04% | Baird | $117 → $75 | Maintains | Outperform |
| 05/13/2022 | 53.04% | Truist Securities | $95 → $85 | Maintains | Buy |
| 05/13/2022 | 15.23% | Morgan Stanley | $138 → $64 | Maintains | Overweight |
| 05/13/2022 | 26.04% | Raymond James | $140 → $70 | Maintains | Strong Buy |
| 05/13/2022 | -18.98% | RBC Capital | $90 → $45 | Maintains | Sector Perform |
| 05/13/2022 | — | Needham | Downgrades | Buy → Hold | |
| 03/24/2022 | 98.06% | Truist Securities | $120 → $110 | Maintains | Buy |
| 03/02/2022 | 40.44% | Needham | $100 → $78 | Maintains | Buy |
| 02/09/2022 | 148.47% | Morgan Stanley | $150 → $138 | Maintains | Overweight |
| 02/09/2022 | 80.05% | Needham | $131 → $100 | Maintains | Buy |
| 01/25/2022 | 170.08% | Morgan Stanley | → $150 | Upgrades | Equal-Weight → Overweight |
| 11/09/2021 | 128.66% | Morgan Stanley | $75 → $127 | Maintains | Equal-Weight |
| 11/09/2021 | 170.08% | JP Morgan | $70 → $150 | Upgrades | Underweight → Overweight |
| 11/09/2021 | 101.66% | RBC Capital | $74 → $112 | Maintains | Sector Perform |
| 11/09/2021 | 135.87% | Needham | $84 → $131 | Maintains | Buy |
| 10/14/2021 | 33.24% | RBC Capital | → $74 | Initiates Coverage On | → Sector Perform |
| 08/05/2021 | 35.04% | Morgan Stanley | $70 → $75 | Maintains | Equal-Weight |
| 08/04/2021 | 51.24% | Needham | $78 → $84 | Maintains | Buy |
| 07/27/2021 | 26.04% | Morgan Stanley | $64 → $70 | Maintains | Equal-Weight |
| 05/14/2021 | 15.23% | Morgan Stanley | $71 → $64 | Maintains | Equal-Weight |
| 02/05/2021 | 40.44% | Needham | $82 → $78 | Maintains | Buy |
| 02/05/2021 | 36.84% | UBS | $89 → $76 | Downgrades | Buy → Neutral |
| 02/05/2021 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 02/05/2021 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 11/24/2020 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 11/06/2020 | 17.03% | Morgan Stanley | $68 → $65 | Maintains | Equal-Weight |
| 11/06/2020 | 15.23% | BMO Capital | $70 → $64 | Maintains | Market Perform |
| 11/06/2020 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 11/06/2020 | 29.64% | Needham | $77 → $72 | Maintains | Buy |
| 10/07/2020 | 53.04% | Berenberg | → $85 | Initiates Coverage On | → Buy |
| 09/16/2020 | 8.03% | Loop Capital | → $60 | Initiates Coverage On | → Hold |
| 08/14/2020 | — | Argus Research | Downgrades | Buy → Hold | |
| 08/05/2020 | 22.43% | Morgan Stanley | $70 → $68 | Maintains | Equal-Weight |
| 08/05/2020 | 26.04% | Raymond James | $75 → $70 | Maintains | Strong Buy |
| 08/05/2020 | 8.03% | Rosenblatt | $65 → $60 | Maintains | Neutral |
| 08/05/2020 | 38.64% | Needham | $79 → $77 | Maintains | Buy |
| 08/05/2020 | 9.83% | JP Morgan | $72 → $61 | Downgrades | Overweight → Neutral |
| 07/20/2020 | 0.83% | Barclays | $42 → $56 | Maintains | Underweight |
| 06/11/2020 | 44.04% | SunTrust Robinson Humphrey | $75 → $80 | Maintains | Buy |
| 05/15/2020 | 60.24% | UBS | $98 → $89 | Maintains | Buy |
| 05/15/2020 | 26.04% | Deutsche Bank | $65 → $70 | Maintains | Outperform |
| 05/15/2020 | 26.04% | Morgan Stanley | $50 → $70 | Maintains | Equal-Weight |
| 05/15/2020 | 17.03% | Rosenblatt | $45 → $65 | Maintains | Neutral |
| 05/15/2020 | 42.24% | Needham | $74 → $79 | Maintains | Buy |
| 04/27/2020 | 33.24% | Needham | $108 → $74 | Maintains | Buy |
| 04/14/2020 | 35.04% | SunTrust Robinson Humphrey | $85 → $75 | Maintains | Buy |
| 04/14/2020 | -9.97% | Morgan Stanley | → $50 | Downgrades | Overweight → Equal-Weight |
| 04/07/2020 | -18.98% | Rosenblatt | → $45 | Initiates Coverage On | → Neutral |
| 04/03/2020 | 0.83% | Raymond James | $86 → $56 | Maintains | Strong Buy |
| 03/27/2020 | 0.83% | Goldman Sachs | $57 → $56 | Maintains | Sell |
| 03/25/2020 | -9.97% | Morgan Stanley | $83 → $50 | Maintains | Overweight |
| 02/05/2020 | 54.84% | Raymond James | $83 → $86 | Maintains | Strong Buy |
| 02/05/2020 | — | Wedbush | Downgrades | Outperform → Neutral | |
| 02/05/2020 | 29.64% | BMO Capital | $78 → $72 | Downgrades | Outperform → Market Perform |
| 02/03/2020 | 49.44% | Raymond James | → $83 | Upgrades | Market Perform → Strong Buy |
| 01/14/2020 | 53.04% | SunTrust Robinson Humphrey | $80 → $85 | Maintains | Buy |
| 01/13/2020 | 76.45% | UBS | $68 → $98 | Upgrades | Neutral → Buy |
| 01/10/2020 | 13.43% | Barclays | → $63 | Downgrades | Equal-Weight → Underweight |
| 12/20/2019 | 18.83% | Barclays | $65 → $66 | Maintains | Equal-Weight |
| 11/06/2019 | 22.43% | BMO Capital | $71 → $68 | Maintains | Outperform |
| 10/15/2019 | 27.84% | BMO Capital | $73 → $71 | Maintains | Outperform |
| 10/11/2019 | 44.04% | Oppenheimer | $85 → $80 | Maintains | Outperform |
| 10/03/2019 | 44.04% | SunTrust Robinson Humphrey | → $80 | Initiates Coverage On | → Buy |
| 09/17/2019 | 44.04% | Cowen & Co. | $100 → $80 | Maintains | Outperform |
| 09/17/2019 | 44.04% | Morgan Stanley | $84 → $80 | Maintains | Overweight |
| 09/17/2019 | 38.64% | Baird | $84 → $77 | Maintains | Outperform |
| 09/17/2019 | 11.63% | UBS | $73 → $62 | Maintains | Neutral |
| 08/26/2019 | 13.43% | Barclays | → $63 | Initiates Coverage On | → Equal-Weight |
| 08/21/2019 | 51.24% | Morgan Stanley | $104 → $84 | Maintains | Overweight |
| 08/12/2019 | — | Argus Research | Upgrades | Hold → Buy | |
| 08/07/2019 | 87.25% | Morgan Stanley | $115 → $104 | Maintains | Overweight |
| 08/07/2019 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 08/07/2019 | — | First Analysis | Downgrades | Strong Buy → Neutral | |
| 06/07/2019 | 49.44% | Goldman Sachs | → $83 | Initiates Coverage On | → Sell |
| 01/15/2019 | — | Morgan Stanley | Upgrades | Equal-Weight → Overweight | |
| 12/13/2018 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 11/07/2018 | 108.86% | First Analysis | $114 → $116 | Upgrades | Outperform → Strong Buy |
| 08/08/2018 | 83.65% | Morgan Stanley | $80 → $102 | Maintains | Equal-Weight |
| 08/08/2018 | 110.66% | BMO Capital | $110 → $117 | Maintains | Outperform |
| 07/17/2018 | — | Argus Research | Initiates Coverage On | → Hold | |
| 07/11/2018 | 89.05% | DA Davidson | → $105 | Initiates Coverage On | → Neutral |
| 06/27/2018 | 44.04% | Morgan Stanley | $73 → $80 | Maintains | Equal-Weight |
| 06/25/2018 | 125.06% | Deutsche Bank | → $125 | Initiates Coverage On | → Buy |
| 06/06/2018 | 31.44% | Morgan Stanley | $67 → $73 | Maintains | Equal-Weight |
| 06/06/2018 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 06/05/2018 | 107.06% | Baird | $88 → $115 | Maintains | Outperform |
| 06/05/2018 | 98.06% | BMO Capital | $95 → $110 | Maintains | Outperform |
| 06/05/2018 | 108.86% | Wedbush | $93 → $116 | Maintains | Outperform |
| 05/09/2018 | 20.63% | Morgan Stanley | $61 → $67 | Maintains | Equal-Weight |
| 05/09/2018 | — | BMO Capital | Upgrades | Market Perform → Outperform | |
| 03/19/2018 | 54.84% | Keybanc | $70 → $86 | Maintains | Overweight |
| 02/23/2018 | 54.84% | Wedbush | → $86 | Initiates Coverage On | → Outperform |
| 02/07/2018 | 22.43% | Baird | $65 → $68 | Maintains | Outperform |
| 02/07/2018 | 27.84% | BMO Capital | $68 → $71 | Maintains | Market Perform |
| 01/12/2018 | 22.43% | BMO Capital | → $68 | Initiates Coverage On | → Market Perform |
| 12/12/2017 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 11/09/2017 | -4.57% | UBS | $47 → $53 | Maintains | Neutral |
| 11/08/2017 | 0.83% | JMP Securities | $54 → $56 | Maintains | Market Outperform |
| 11/08/2017 | -6.37% | Morgan Stanley | $48 → $52 | Maintains | Equal-Weight |
| 11/08/2017 | 2.63% | Keybanc | $52 → $57 | Maintains | Overweight |
| 10/23/2017 | 24.23% | Needham | → $69 | Initiates Coverage On | → Buy |
New Relic Questions & Answers
What is the target price for New Relic (NEWR)?
The latest price target for New Relic (NYSE: NEWR) was reported by Credit Suisse on September 23, 2022. The analyst firm set a price target for $78.00 expecting NEWR to rise to within 12 months (a possible 40.44% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for New Relic (NEWR)?
The latest analyst rating for New Relic (NYSE: NEWR) was provided by Credit Suisse, and New Relic initiated their outperform rating.
When is the next analyst rating going to be posted or updated for New Relic (NEWR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of New Relic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for New Relic was filed on September 23, 2022 so you should expect the next rating to be made available sometime around September 23, 2023.
Is the Analyst Rating New Relic (NEWR) correct?
While ratings are subjective and will change, the latest New Relic (NEWR) rating was a initiated with a price target of $0.00 to $78.00. The current price New Relic (NEWR) is trading at is $55.54, which is within the analyst's predicted range.